Login / Signup

Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes-Good or excellent?

Aviv A ShaulAlon Eisen
Published in: Diabetes/metabolism research and reviews (2017)
Keyphrases
  • oral anticoagulants
  • atrial fibrillation
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • metabolic syndrome